Watchful Waiting and Active Surveillance

What Are Watchful Waiting and Active Surveillance?

Prostate cancer is one of the most commonly diagnosed cancers among men, with approximately one in nine men in the United States developing the disease during their lifetime. Because many prostate cancers grow slowly, immediate treatment is not always necessary. In these cases, physicians may recommend management strategies known as watchful waiting or active surveillance.

While both approaches avoid immediate treatment, they serve different purposes and are recommended for different patient populations. Understanding the distinction between the two can help patients feel more confident in their care decisions.

Watchful Waiting

Watchful waiting is a less aggressive management strategy that focuses on symptom control rather than routine cancer monitoring. It is most often recommended for older men or for patients with significant medical conditions who may not benefit from—or may be harmed by—aggressive prostate cancer treatment.

With watchful waiting, regular intensive testing is not typically required. Instead, patients attend periodic checkups to assess overall health and monitor for the development of symptoms. If prostate cancer begins to cause discomfort or interfere with quality of life, treatment is initiated with the goal of relieving symptoms rather than curing the disease. This approach prioritizes comfort and quality of life, particularly when life expectancy or other health concerns limit the benefits of definitive treatment.

Active Surveillance

Active surveillance is a more structured and proactive approach, most commonly recommended for men with low-risk, early-stage prostate cancer that is unlikely to spread quickly. The goal of active surveillance is to carefully monitor the cancer while preserving the option for curative treatment if the disease shows signs of progression.

Patients undergoing active surveillance typically follow a regular monitoring schedule that may include PSA blood tests, digital rectal exams (DRE), imaging studies, and periodic prostate biopsies. By closely tracking changes over time, physicians can identify early signs that the cancer is becoming more aggressive and initiate treatment at an optimal point—before the disease advances, but without exposing patients to unnecessary side effects too early.

Choosing the Right Approach

Both watchful waiting and active surveillance are based on the understanding that not all prostate cancers pose an immediate threat to health or longevity, and that treatments such as surgery or radiation can carry significant risks and long-term side effects.

The decision between these two approaches depends on several factors, including age, overall health, life expectancy, cancer stage and Gleason score, personal values, and comfort with ongoing monitoring. A thorough discussion with your physician is essential to determine the most appropriate strategy for your individual situation.

By selecting the right management plan, patients can balance effective cancer care with quality of life—ensuring treatment is delivered when and if it is truly needed.